US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

665.74

-8.4209-1.25%

Number of Gainers:70

Number of Losers:70

Number of Flat:13

PE:- -

High:687.10

Open:668.22

Low:665.46

Close:674.17

Volume:277.51M

Turnover:11.28B

Market Cap:459.41B

Float Cap:358.92B

Loading ...

SEC Grants Five-Year Exemption: Compliant Pathway for Tokenized US Stocks and the Emerging Winners

Mobix Labs, - Expects Q4 2026 Revenue to Exceed $1.60 Mln, over 100% Sequential Increase

THOMSON REUTERS

Mobix Labs Sees over 100% Q4 Revenue Growth, Substantially Higher Gross Margin

THOMSON REUTERS

NYSE Halt News Pending Lst $8.580000

THOMSON REUTERS

Digital Brands announces growth, marketing efficiency across AVO

HCW Biologics Prices USD 1.5 Million Private Placement at USD 1.6599 Per Unit

HCW Biologics Announces Pricing of $1.5 Million Private Placement

THOMSON REUTERS

Digital Brands Group Targets 5x ROAS as AVO Revamps E-Commerce Platform in October

Digital Brands Group Says AVO Revenue Rises 221% in Aug. 1-Sept. 11 Period

Digital Brands Group Delivers 221% Revenue Growth While Cutting Marketing Spend by 78%

THOMSON REUTERS

Absci Targets Mid-2027 Start for Phase 2 Storyline Trial of ABS-201 in Endometriosis Pain

Mobix Labs Expects Fiscal Q4 Revenue to Exceed $1.6 Million, Above Midpoint of Guidance

THOMSON REUTERS

Absci Announces Preliminary Details for Phase 2 Storyline™ Trial of AI-Designed Antibody Abs-201™ for Endometriosis

THOMSON REUTERS

Absci Corp - Phase 2 Trial Initiation Anticipated in Mid-2027

THOMSON REUTERS

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

SimilarWeb CEO or Offer Disposes of USD 529,934.14 in Common Shares

Turn Therapeutics Initiated at Buy by LUCID Capital Markets

Immuneering MAPKeeper-301 Phase 3 Pancreatic Cancer Trial Abstract Wins ESMO 2026 Poster Slot

Frontier Group Holdings, Inc. : UBS Cuts Target Price to $6 from $7

THOMSON REUTERS

Press Release: Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for up to $47 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK4539/news?page=25"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":665.74475,"timestamp":1790971199999,"preClose":674.16565,"halted":0,"volume":277513529,"delay":0,"changeRate":-0.012491,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-8.420898,"latestTime":"10-02 16:00:00 EDT","open":668.2159,"high":687.09705,"low":665.4622,"amount":11275023470.157156,"amplitude":0.032091,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.201059,"peRate":114.807925,"turnoverRate":0.021835,"increases":70,"decrements":70,"flats":10,"marketCap":459409451462.5,"floatMarketCap":358922617098.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":687.09705,"amplitude":0.032091,"preClose":674.16565,"low":665.4622,"pbRate":"5.201059","latestPrice":665.74475,"volume":277513529,"delay":0,"open":668.2159,"prevYearClose":881.5255,"prevWeekClose":697.624,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":697.624,"twentyDayClose":733.4782,"sixtyDayClose":783.9062,"secType":"PLATE","market":"US","turnoverRate":0.021835,"peRate":114.807925,"marketCap":459409451462.5,"floatMarketCap":358922617098.875,"timestamp":1790971199999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":70,"down":70,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:25,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174564304","title":"SEC Grants Five-Year Exemption: Compliant Pathway for Tokenized US Stocks and the Emerging Winners","url":"https://stock-news.laohu8.com/highlight/detail?id=1174564304","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174564304?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:44","pubTimestamp":1790257498,"startTime":"0","endTime":"0","summary":"According to Woofun AI, the US Securities and Exchange Commission (SEC) has formally issued a five-year \"Innovation Exemption,\" creating the first federally compliant pathway for on-chain trading of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIX","ICRC","COIG","BK4595","07711","LU1668664300.SGD","CONI","BLCK","BK4161","BK4516","LU0106831901.USD","BK4585","FIAT","COIO","BK4596","DAPP","CRCL","FINX","LU1861220207.SGD","LU1791807156.HKD","BK4551","BK4539","BK4023","COYY","07311","LU2360107671.USD","BKCH","CCUP","CONY","CRCG","LU1861559042.SGD","BK4535","BK4112","COIW","BK4588","CONL","CRCO","CLOB","BK4600","BITQ","COIA","ICOI","FDIG","CRCA","IBLC","CRCD","CONX","COII","LU1861558580.USD","ATS","CIR","COIN","CRPT","09311","LU1861217088.USD","BK4554","09711"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669959964","title":"Mobix Labs, - Expects Q4 2026 Revenue to Exceed $1.60 Mln, over 100% Sequential Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2669959964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669959964?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:40","pubTimestamp":1790257201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA85MRN6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","MOBX","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669495995","title":"Mobix Labs Sees over 100% Q4 Revenue Growth, Substantially Higher Gross Margin","url":"https://stock-news.laohu8.com/highlight/detail?id=2669495995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669495995?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:40","pubTimestamp":1790257201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA85MRN6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4141","MOBX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669495849","title":"NYSE Halt News Pending Lst $8.580000","url":"https://stock-news.laohu8.com/highlight/detail?id=2669495849","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669495849?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:29","pubTimestamp":1790256567,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nAQN2MKNI4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SMWB","BK4023","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669498485","title":"Digital Brands announces growth, marketing efficiency across AVO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669498485","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669498485?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:36","pubTimestamp":1790253382,"startTime":"0","endTime":"0","summary":"Digital Brands (DBGI) Group announced significant growth and improved marketing efficiency across its collegiate licensing brand, AVO. From August ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/digital-brands-announces-growth-marketing-efficiency-across-avo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/digital-brands-announces-growth-marketing-efficiency-across-avo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4122","DBGI","BK4094","AVO","BK4212","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669835498","title":"HCW Biologics Prices USD 1.5 Million Private Placement at USD 1.6599 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2669835498","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669835498?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:25","pubTimestamp":1790252717,"startTime":"0","endTime":"0","summary":"HCW Biologics prices USD 1.5 million private placement at USD 1.6599 per unitHCW Biologics priced a USD 1.5 million private placement with an existing stockholder.Deal covers 903,614 units priced at U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDLxd5xN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","SG9999014021.USD","BK4139","SG9999014039.USD","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","BK4112","BK4585","SG9999014013.SGD","BK4588","HCWB","BK4539","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669988834","title":"HCW Biologics Announces Pricing of $1.5 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669988834","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669988834?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:25","pubTimestamp":1790252700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA6LC3FC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","HCWB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460758","title":"Digital Brands Group Targets 5x ROAS as AVO Revamps E-Commerce Platform in October","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460758","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460758?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:18","pubTimestamp":1790252310,"startTime":"0","endTime":"0","summary":"Digital Brands Group targets 5x ROAS as AVO revamps e-commerce platform in OctoberDigital Brands Group set a target of achieving 5x return on ad spend to support scaling digital advertising alongside ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL7Tf6xL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DBGI","BK4539","BK4094","BK4122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460730","title":"Digital Brands Group Says AVO Revenue Rises 221% in Aug. 1-Sept. 11 Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460730","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460730?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:18","pubTimestamp":1790252300,"startTime":"0","endTime":"0","summary":"Digital Brands Group says AVO revenue rises 221% in Aug. 1-Sept. 11 periodDigital Brands Group posted 221% year-over-year revenue growth at collegiate licensing brand AVO from Aug. 1 to Sept. 11, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL14DwG9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4094","BK4122","DBGI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669607374","title":"Digital Brands Group Delivers 221% Revenue Growth While Cutting Marketing Spend by 78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669607374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669607374?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:18","pubTimestamp":1790252280,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA9BVKV2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4094","BK4122","DBGI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460682","title":"Absci Targets Mid-2027 Start for Phase 2 Storyline Trial of ABS-201 in Endometriosis Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460682?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:01","pubTimestamp":1790251264,"startTime":"0","endTime":"0","summary":"Absci targets mid-2027 start for Phase 2 STORYLINE trial of ABS-201 in endometriosis painAbsci outlined a planned Phase 2 STORYLINE trial for ABS-201, an AI-designed antibody for endometriosis-associa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL9N0pHX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4539","ABSI","LU2210150020.SGD","SG9999014039.USD","LU2095319765.USD","BCDF","SG9999014013.SGD","LU2210149790.SGD","BK4112","IE00BN0W2T93.GBP","BK4585","BK4139","IE00BN0W2W23.USD","IE00BGHQF748.EUR","SG9999014021.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","ARKG","LU0314104364.USD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","BK4588","IE00B3QW5Z07.USD","NDAQ","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460329","title":"Mobix Labs Expects Fiscal Q4 Revenue to Exceed $1.6 Million, Above Midpoint of Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460329","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460329?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251204,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUACFJ4MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4141","BK4539","MOBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460378","title":"Absci Announces Preliminary Details for Phase 2 Storyline™ Trial of AI-Designed Antibody Abs-201™ for Endometriosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460378?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA9NX8D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","ARKG","ABSI","BK4139","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669348460","title":"Absci Corp - Phase 2 Trial Initiation Anticipated in Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669348460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669348460?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA9NX8D3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABSI","BK4539","ARKG","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669934124","title":"Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669934124","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669934124?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251200,"startTime":"0","endTime":"0","summary":"Late-breaking presentation will highlight Phase 2b clinical data for MAR001, a potential first-in-class antibody targeting ANGPTL4 designed to lower triglycerides and improve metabolic functionSOUTH S","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368262/18623/en/marea-therapeutics-a-subsidiary-of-lisata-therapeutics-announces-upcoming-late-breaking-presentation-of-mar001-clinical-data-at-the-american-heart-association-scientific-sessions-2.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4518","BK4117","LPL","LENZ","BK4148","BK4107","BK4007","AFG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460830","title":"SimilarWeb CEO or Offer Disposes of USD 529,934.14 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460830","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460830?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:57","pubTimestamp":1790251036,"startTime":"0","endTime":"0","summary":"SimilarWeb CEO Or Offer disposes of USD 529,934.14 in common sharesSimilarWeb CEO Or Offer sold 34,500 ordinary shares on Sept. 22, 2026 at a weighted average USD 8.3778.Disposed of 28,400 ordinary sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL8BrMBM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"SimilarWeb CEO or Offer Disposes of USD 529,934.14 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","SMWB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669467786","title":"Turn Therapeutics Initiated at Buy by LUCID Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2669467786","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669467786?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:49","pubTimestamp":1790250540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TTRX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TTRX","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669467616","title":"Immuneering MAPKeeper-301 Phase 3 Pancreatic Cancer Trial Abstract Wins ESMO 2026 Poster Slot","url":"https://stock-news.laohu8.com/highlight/detail?id=2669467616","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669467616?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:31","pubTimestamp":1790249469,"startTime":"0","endTime":"0","summary":"Immuneering MAPKeeper-301 Phase 3 pancreatic cancer trial abstract wins ESMO 2026 poster slotImmuneering flagged an ongoing Phase 3 MAPKeeper-301 trial of atebimetinib with chemotherapy in first-line ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL4MqBjZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","SG9999014039.USD","IE00BQXX3D17.EUR","IMRX","BK4112","SG9999014005.SGD","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","BK4539","SG9999014021.USD","BK4563","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669446786","title":"Frontier Group Holdings, Inc. : UBS Cuts Target Price to $6 from $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2669446786","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669446786?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:23","pubTimestamp":1790248990,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nAZN4TLSCQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ULCC","BK4008","BK4500","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462637","title":"Press Release: Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for up to $47 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462637","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669462637?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:00","pubTimestamp":1790247600,"startTime":"0","endTime":"0","summary":"JUPITER, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it has entered into a financing agreement with AvenCell Therapeutics, Inc., a ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4099","BK4139","BK4588","BK4230","BK4604","LU0566484027.USD","BK4007","R","03160","LU1559883803.SGD","LGND","TM","LENZ","IE0009354923.USD","BK4232","BK4555","CAR","BK4022","BK4539","HELX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":39,"pageCount":25,"totalSize":771,"code":"91000000","status":"200"}]}}